| Course | NS460 Dietary Supplements and Nutraceuticals |
|---|---|
| Unit | Unit 2 |
| Paper type | Regulatory brief |
| Length | About 770 words, 5 pages double-spaced |
| Format | APA 7 student paper |
| School | Purdue University Global |
| Program | BS in Nutrition Science |
| Updated | October 2026 |
Free sample paper for NS460 Unit 2
No One Approves It, but Someone Is Watching: A Unit 2 Regulatory Brief for Two Founders Launching a Lion's Mane Gummy
[Student Name]
Purdue University Global
NS460: Dietary Supplements and Nutraceuticals
Unit 2 Regulatory Brief
[Instructor Name]
[Date]
The founders and their product are composite; the statute and regulations cited are real and are summarized, not given as legal advice.
Memo
To: Dana and Luis, founders. From: NS460 student. Re: What federal law requires before you sell your lion's mane gummy.
Summary: No federal agency will approve your gummy before you sell it. Under the Dietary Supplement Health and Education Act, dietary supplements reach the market without premarket approval, and the company, not the FDA, is responsible for making sure the product is safe and its label truthful (Dietary Supplement Health and Education Act of 1994, 1994). The FDA can act after a product is on the market if it is unsafe, mislabeled or making drug claims. Several obligations still apply before and after launch.
Before Launch
Ingredient status. The law treats ingredients marketed in the United States before October 15, 1994, differently from newer ones. A new dietary ingredient requires a notification to the FDA at least 75 days before marketing, with the safety evidence the company relies on (21 U.S.C. § 350b, 2024).
Whether your specific lion's mane ingredient counts as a new dietary ingredient is the one question you should pay an attorney to answer before you order packaging.
Lion's mane has a long history as a food mushroom, but the answer may depend on which part is used, the fruiting body or mycelium grown on grain, and how it is extracted. Those details can make an ingredient different from what was sold before 1994.
Manufacturing. Whoever makes the gummy must follow current good manufacturing practice rules for supplements, which require written specifications, testing of identity for each ingredient, batch records and complaint files (21 C.F.R. § 111, 2024). If you use a contract manufacturer, you remain responsible for the product, so ask to see their records and certificates of analysis.
Facility registration. Facilities that make or store the gummies must be registered with the FDA as food facilities.
On the Label
Statement of identity. The label must call the product a dietary supplement.
Supplement Facts panel. It must list the serving size, the amount of lion's mane per serving and the other ingredients, including the gelatin or pectin, sweeteners and colors.
Claims. You may describe how an ingredient affects the structure or function of the body, such as "supports focus," but not claim to diagnose, treat, cure or prevent a disease, such as "helps with ADHD" or "prevents dementia." Any structure or function claim must carry the standard FDA disclaimer, printed with an asterisk beside the claim, and you must notify the FDA of the claim within 30 days of first marketing it (21 C.F.R. § 101.93, 2024).
Evidence. The Federal Trade Commission expects health claims in advertising, including social media and influencer posts, to rest on solid scientific support, which in practice means well-designed human studies on the product or its ingredient at the dose sold (Federal Trade Commission, 2022). A claim that the gummy "boosts focus" will need that kind of support.
After Sale
Adverse events. If you receive a report of a serious adverse event, such as a hospitalization, you must report it to the FDA within 15 business days, and your label must include a domestic address or phone number for consumers to report problems (21 U.S.C. § 379aa-1, 2024). Keep records of all reports for six years. Serious events include death, a life-threatening reaction, hospitalization, lasting disability or a birth defect, and they must be sent with a copy of the label. Less serious complaints, such as an upset stomach, do not have to be reported, but they belong in your complaint file, because a pattern of minor complaints may point to a problem with a batch.
Monitoring. The FDA can inspect facilities, test products and issue warning letters, and it can seek to remove a product it finds adulterated or misbranded.
Common Mistakes to Avoid
1. Quoting customer reviews that mention a disease.
2. Using words like "clinically proven" without studies on your product or ingredient.
3. Adding ingredients, such as caffeine, without updating the label and safety review.
4. Assuming a manufacturer's certificate of analysis replaces your own identity testing.
Next Steps
Ask an attorney with dietary supplement experience to determine your ingredient's status and review your label. Request your manufacturer's cGMP audit records. Gather the human studies on lion's mane before writing any claim.
References
21 C.F.R. § 111 (2024). https://www.ecfr.gov/current/title-21/part-111
21 C.F.R. § 101.93 (2024). https://www.ecfr.gov/current/title-21/section-101.93
Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417, 108 Stat. 4325 (1994).
Federal Trade Commission. (2022). Health products compliance guidance. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
21 U.S.C. § 379aa-1 (2024).
21 U.S.C. § 350b (2024).
The Purdue Global NS460 Unit 2 instructions
In Unit 2, NS460 asks students to write a brief explaining how federal law applies to a specific supplement product. Prompts typically assign a reader who is about to sell something, then ask what applies before launch, on the label and after sale. Start with a summary that corrects the reader's main misunderstanding. Organize the obligations by timing so the reader can act in order. Cite the statute or regulation for each requirement. Explain claims carefully, with examples of allowed and forbidden wording. Include advertising rules, since the FTC governs what is said outside the label. Cover adverse event reporting. Identify any question you cannot answer and say who can. Avoid giving legal advice. Keep the memo format and stay near the length the prompt sets, often three to four pages.
How this NS460 Unit 2 example is built
The sample opens with a memo heading and a summary stating that no agency will approve the gummy. The before-launch section covers ingredient status and the 75-day notification rule, and a highlighted sentence isolates the attorney question. A paragraph explains why the fruiting body versus mycelium distinction could matter. Manufacturing rules and facility registration follow. The label section covers the statement of identity, the Supplement Facts panel, structure and function claims with examples, the disclaimer and the 30-day notice. FTC substantiation is described in plain terms. The after-sale section explains serious adverse event reporting, record keeping and FDA enforcement. A list of common mistakes and three next steps close the brief.
Where the points sit in the NS460 Unit 2 rubric
Regulatory briefs are usually scored on legal accuracy, organization, usefulness to the named reader and appropriate scope. The largest share of points tends to rest on getting the law right: no premarket approval, the company's responsibility, claim rules and reporting duties. Citing the specific statute or regulation for each obligation shows rigor. Instructors reward briefs organized around what the reader must do and when. Examples of permitted and forbidden claims make the guidance practical. Recognizing a question that requires legal advice, and saying so, shows good judgment. Plain language suited to a non-expert reader matters. Memo format and correctly formatted legal and agency references complete the rubric.
Common NS460 Unit 2 mistakes, and how to avoid them
Common errors in supplement briefs include saying the FDA approves supplements or that registration means approval. Others describe DSHEA without applying it to the product in question. Writers often skip FTC advertising rules, though social media claims cause many problems. Disease claims and structure or function claims get confused. Adverse event reporting is left out or misstated. Some briefs give legal advice the writer cannot give. The reader's actual product details are ignored. If you have a product and a reader in mind but are unsure which rules apply, a writer can help you sort the obligations by timing and cite each one.
Get an NS460 Unit 2 example written to your instructions
Whatever product and reader the Unit 2 scenario names, forward it with the rubric and any required citation style. The brief is ordered around that reader's actual question, each duty is cited to statute or regulation, and open points are routed rather than guessed. First sample free; delivery inside 24-48h. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
More NS460 papers and BS in Nutrition Science samples
- NS460 Unit 1: Biotin Gummy Discussion Post
- NS460 Unit 3: Label Analysis
- NS460 Unit 4: Supplement Monograph
- NS460 Unit 5: Seminar Reflection
- NS460 Unit 6: Interaction Review
- NS460 Unit 7: Botanical Case Study
- NS460 Unit 8: Consumer Handout
- NS460 Unit 9: Systematic Review Summary
- NS460 Unit 10: Final Product Review
- NS455 Unit 2: Late Eating Headline Critique
- NS420 Unit 2: Intake Interview Script
- NS410 Unit 2: Pantry Needs Assessment
- NS325 Unit 2: Vegetarian Prenatal Plan
NS460 Unit 2 questions, answered
Do I have to explain the whole of DSHEA?
No. A brief is judged on whether it answers its reader, so cover the provisions that touch the product in front of you and mention the rest in a sentence. For most scenarios that means the supplement definition, safety responsibility, new dietary ingredients, labeling and claims, manufacturing practice and adverse event reporting. Citing section numbers where you rely on them lets a grader check you quickly.
Is FDA registered the same as FDA approved?
No, and briefs that blur the two lose accuracy credit. Facilities that make food, supplements included, generally register with the agency, which gives it a list of who makes what and where. Registration involves no review of the product, its safety or its claims. One plain sentence explaining that difference is often worth more than a paragraph of legislative history.
Should the brief say whether the product works?
Usually not, unless your prompt asks for it. This unit is about the law, and evidence of benefit belongs to later assignments, where monographs and reviews weigh the trials. One line noting that the law requires no proof of benefit before sale is enough. An efficacy verdict tends to lengthen the brief without answering the regulatory question your reader asked.
Where can I find a free NS460 Unit 2 sample paper?
A complete Unit 2 regulatory brief is on this page, explaining to two founders what federal law requires before, on and after launch of a lion's mane gummy, and flagging the question an attorney must answer.
Does the FDA approve supplements before sale, per the NS460 Unit 2 sample?
No. Under the 1994 supplement law, products reach the market without premarket approval. The company is responsible for safety and truthful labeling, and the FDA can act afterward against unsafe or mislabeled products.